Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

SARS-COV-2 Infection Among Hospital Staff: Study of Professional and Individual Factors of Covi-19 and Impact on Return to Work

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05616663

Acronym

FP-COVID-19

Enrollment

639

Registered

2022-11-15

Start date

2020-07-31

Completion date

2023-12-16

Last updated

2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

COVID-19, SARS-COV-2

Brief summary

Started on January 9, 2020 with the announcement of the discovery of a new SARS-CoV-2 coronavirus, the Covid-19 pandemic is responsible as of June 21, 2020 for 160,377 confirmed cases in France, 29,640 deaths and 9,823 hospitalizations. The Grand Est region is one of the regions in France that was most precociously and strongly affected by the epidemic, in particular the Strasbourg University Hospital. Faced with the heavy use of the healthcare system, hospital staff of all categories are an essential resource to be preserved. Several studies have shown the significant impact of Covid-19 on doctors and caregivers. In order to better protect these personnel and avoid contamination that could be harmful to their health but also because of the consequences in terms of staff, it is necessary to better understand the risk factors for transmission of this infection, the means of protection, the evolution of the disease and the determinants of the return to work. Few studies have explored on such a large workforce and in detail the professional risk factors for developing Covid-19 within different groups of hospital professionals including also non-caregivers and the evolution when returning to work in an outpatient population.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Major subject (≥18 years old) * Professionals from the University Hospitals of Strasbourg (HUS) * Professionals who had been working at the HUS at the time of the diagnosis of SARS CoV-2 infection. * Subject having not expressed, after being informed, opposition to the reuse of their data for research purposes

Exclusion criteria

\- Subject who expressed their opposition to participating in the study

Design outcomes

Primary

Measure	Time frame	Description
positive RT-PCR test	one week after infection with Covid-19	The presence of SARS CoV 2 infection is assessed by a positive RT-PCR test

Countries

France

Contacts

Primary ContactMaria GONZALEZ, MD, PhD

maria.gonzalez@chru-strasbourg.fr33 3 88 11 64 66

Outcome results